GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
Did you join LSE just so you could act like the great savior of investors who know no better. But thanks to your detailed missives they now buy war bonds instead ? I repeat , this site is for the sharing of ideas/info and general chat about shares which interest one. In this case its KMK.
I as posted below have already bought a significant amount of these. And I am posting my info and thought on here as this is a share based financial chat room/bulletin board specifically set up for this one single purpose alone. What do you post here for with your sporadic attacks on me ? The point is ?
This unless you hadn't noticed is a financial based bulletin board. It exists specifically for the purpose of people posting info and thoughts on companies that interest them. Why are you here again ? Oh yeah that's right , to not post ANYTHING ever. Se eh , how does that work then ? Why did you join ?
The US Army are working with them to get a hand held unit for every soldier in the field and at $4k a pop this would amount to over $800m YES you read that correctly thats $800M dollars just for a standard order of 200 thousand units hand held. This is not fantasy this is whats being worked on. As ever go and read up on it and make a few phone calls. GL.
Remember DARPA intend on rolling out the device after their recent trials in Washington. They have earmarked 23 cities with another 4 being added rather quickly. KMK estimate the value per city is around 10m each. That could be Dollars but either way its clear that this has significant upside. Each one of these cities is currently worth their entire current income alone. There are 27 being planned for first roll out. And Darpa are helping get it out there into the European market. Let me say this, the company (not me) the company think there will be HUGE gains to come in the immediate future. Now thats all Im saying as thats what I have been led to believe but I have no reason to doubt it. You do what you think is best as an investor and do your own investigations and research . GL. The directors think KMK is significantly undervalued and are astonished that considering their US Government tie in that the SP is not much much higher.
Kromek are looking for BIG deals they are out there right now negotiating massive deals. If just one of those deals gets signed it would be more than the mkt cap as it stands today. Thats what the directors of Kromek say. It is hard for them to say much about deals as they are with the US Government and the nature of the product means security has to be tight. I get the impression though that we wont have to wait too long to hear something you might like.
The ‘dirty bomb’ threat is growing. Islamic State is collecting radioactive materials and other dangerous chemicals as it powers through the Middle East – and even Nato is worried about what the murderous regime plans to do with them. Kromek, an AIM-listed company spun out of Durham University, has devised a way to minimise the threat posed by this kind of terrorist activity.
More from the Daily Mails Midas tip Notice they tip it at 33p!! The ‘dirty bomb’ threat is growing. Islamic State is collecting radioactive materials and other dangerous chemicals as it powers through the Middle East – and even Nato is worried about what the murderous regime plans to do with them. Kromek, an AIM-listed company spun out of Durham University, has devised a way to minimise the threat posed by this kind of terrorist activity. The shares are 33½p and should increase significantly over the next few years. Kromek uses a chemical compound known as CZT to produce radiation detection equipment that is capable of identifying hazardous emissions, taking accurate readings of those emissions and sending the data back to an information centre, where it can be downloaded and analysed by experts.
More of the Daily Mail Midas tip "Discussions are also being held with governments around the world, as Kromek’s pocket detectors could become a routine part of police and army surveillance, helping to identify and deal with nuclear threats. The detectors could also be used at nuclear plants, both when they are in use and when being decommissioned. Basu was Kromek’s first employee when the firm was founded in 2005. The CZT technology developed at Durham University has so many potential applications that one of the principal challenges Basu faced was working out what to do with it. Over the past decade, the answers have become increasingly clear and Kromek is now focused on a cluster of markets, each of which has significant potential. "
Oh and here is rather more of the Midas article with no selective censoring. "Kromek’s technology is used in devices including probes that can evaluate how and whether cancer is spreading in a patient and sophisticated machines that highlight conditions ranging from osteoporosis to heart disease. Some of this equipment is already on the market and some is in development, but Kromek is working with is working with top medical suppliers to make CZT products available in hospitals around the world. Kromek joined AIM in October 2013 at 51p. In its first year as a public company, it disappointed investors with lower-than-expected revenues. The shortfall arose because a couple of large orders were delayed from one year to the next, but the market was spooked and the share price suffered. Kromek will report annual figures to April in a couple of months and brokers forecast sales of £8.1million, rising to £8.4million next year. Pre-tax losses of about £3million are expected, largely because the firm is still investing in research and development and sales are at an early stage. Midas verdict: Investing in lossmaking firms can be high risk, but Kromek’s technology is ground-breaking, the firm is working with some of the biggest organisations in the world and prospects are bright. A potentially rewarding buy for brave investors. "
Telegraph Richard Evans 1 MARCH 2017 • 6:07AM Questor normally takes a dim view of companies that ask their shareholders for more money; we believe that cash should really be flowing in the other direction. But when Kromek, the hi-tech imaging firm, raised £21m from investors earlier this month it was not motivated by a shortage of funds – instead, it strengthened its balance sheet to reassure its most important customers, including the American government, that its finances were rock solid and that it would be able to fulfil long-term supply contracts. The US government, for example, is interested in placing orders with Kromek that could be vital to America’s national security – and very rewarding to the company’s shareholders. We see scope for substantial gains.